S-phase-specific expression of the Mad3 gene in proliferating and differentiating cells

Biochemical Journal

Volumn 359, Issue 2, 2001, Pages 361-367

  Fox, E J ^a   Wright, S C ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Cell cycle; Differentiation; Mad; Myc; Transcription

Indexed keywords

CELL CULTURE; GENES; RNA;

APOPTOSIS;

BIOCHEMISTRY;

BUB1 RELATED PROTEIN; GENE PRODUCT; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; ERYTHROLEUKEMIA CELL; GENE EXPRESSION; MITOSIS; MOUSE; NONHUMAN; ONCOGENE MYC; PRIORITY JOURNAL;

3T3 CELLS; ANIMALS; CELL DIFFERENTIATION; CELL DIVISION; DNA-BINDING PROTEINS; GENE EXPRESSION; HELA CELLS; HUMANS; I-KAPPA B PROTEINS; MICE; RNA, MESSENGER; S PHASE; TUMOR CELLS, CULTURED;

EID: 0035886882     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/0264-6021:3590361     Document Type: Article

References (63)

1. The Myc/Max/Mad network and the transcriptional control of cell behaviour
2. The Max network gone Mad
3. Mechanisms of apoptosis by c-Myc
4. Enforced expression of the c-myc oncogene inhibits cell differentiation by precluding entry into a distinct predifferentiation state in G0/G1
5. Constitutive c-myc oncogene expression blocks mouse erythroleukemia cell differentiation but not committment
6. Proteins of the Myc network: Essential regulators of cell growth and differentiation
7. Myc family oncogenes in the development of normal and neoplastic cells
8. Myc oncogenes and human neoplastic disease
9. Mad: A heterodimeric partner for Max that antagonizes Myc transcriptional activity
10. Mad3 and Mad4: Novel Max-interacting transcriptional repressors that suppress c-Myc dependent transformation and are expressed during neural and epidermal differentiation
11. Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites
12. Suppression of Myc, but not E1a, transformation activity by Max-associated proteins, Mad and Mxi1
13. Effects of the myc ongogene antagonist, MAD, on proliferation, cell cycling and the malignant phenotype of human brain tumour cells
14. Differential effects by Mad and Max on transformation by cellular and viral oncogenes
15. Expression of the mad gene during cell differentiation in vivo and its inhibition of cell growth in vitro
16. Inhibition of cell proliferation by the Mad1 transcriptional repressor
17. Repression of Myc-Ras cotransformation by Mad is mediated by multiple protein-protein interactions
18. Dwarfism and dysregulated proliferation in mice overexpressing the Myc antagonist Mad1
19. Mxi1, a putative tumor suppressor gene, suppresses growth of human glioblastoma cells
20. Inhibition of proliferation and apoptosis by the transcriptional repressor Mad1
21. Inhibition of cell growth and apoptosis by inducible expression of the transcriptional repressor Mad1
22. Max: A helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc
23. Myc and Max associate in vivo
24. Sequence-specific DNA binding by the c-Myc protein
25. Binding of Myc proteins to canonical and noncanonical DNA sequences
26. Transcriptional activities of the Myc and Max proteins in mammalian cells
27. Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max
28. An amino-terminal c-Myc domain required for neoplastic transformation activates transcription
29. New Myc-interacting proteins: A second Myc network emerges
30. The essential cofactor TRRAP recruits the histone acetyltranferase hGCN5 to c-Myc
31. An essential domain of the c-Myc protein interacts with a nuclear factor that is also required for E1A-mediated transformation
32. An ATPase/helicase complex is an essential cofactor for oncogenic transformation by c-Myc
33. Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3
34. Histone deacetylases associated with the mSin3 corepressor mediate Mad transcriptional repression
35. Histone deacetylase activity is required for full transcriptional repression by mSin3A
36. Mad proteins contain a dominant transcription repression domain
37. SIN3-dependent transcriptional repression by interaction with the Mad1 DNA-binding protein
38. Repression by the Mad(Mxi1)-Sin3 complex
39. Direct examination of histone acetylation on Myc target genes using chromatin immunoprecipitation
40. c-Myc target genes involved in cell growth, apoptosis and metabolism
41. The myc oncoprotein: A critical evaluation of transactivation and target gene regulation
42. Myc target genes
43. Expression analysis with oligonucleotide microarrays reveals Myc regulates genes involved in growth, cell cycle, signaling, and adhesion
44. Gene-target recognition among members of the Myc superfamily and implications for oncogenesis
45. Identification of Mad as a repressor of the human telomerase (hTERT) gene
46. A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation
47. Expression of mad, mxi1, max and c-myc during induced differentiation of hematopoietic cells: Opposite regulation of mad and c-myc
48. Function of the c-Myc antagonist Mad1 during a molecular switch from proliferation to differentiation
49. Sequential expression of the Mad family of transcriptional repressors during differentiation and development
50. Targeted disruption of the Myc antagonist Mad1 inhibits cell cycle exit during granulocyte differentiation
51. Role of Mxi1 in aging organ systems and the regulation of normal and neoplastic growth
52. Targeted deletion of the S-phase-specific Myc antagonist Mad3 sensitizes neuronal and lymphoid cells to radiation-induced apoptosis
53. Single-step method of RNA isolation by acid guanidinium thiocyanate phenol chloroform extraction
54. DNA sequences that mediate attenuation of transcription from the mouse proto-oncogene myc
55. Max encodes a sequence specific DNA binding protein and is not regulated by serum growth factors
56. Cell cycle regulation of the human cdc2 gene
57. Analysis of the Myc/Max/Mad network members in adipogenesis: Inhibition of the proliferative burst and differentiation by ectopicaly expressed Mad1
58. Erythroleukemic differentiation
59. Induction of erythroid differentiation in vitro by purines and purine analogues
60. Developmental program of murine erythroleukemia cells
61. Transient inhibition of initiation of S-phase associated with dimethylsulfoxide induction of murine erythroleukemia cells to erythroid differentiation
62. Expression of c-myc changes during differentiation of mouse erytholeukemia cells
63. c-myc mRNA levels in the cell cycle change in mouse erythroleukemia cells following inducer treatment